Altered expression of metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in cervical disc herniation patients

被引:5
|
作者
Zhuang, H. M. [1 ]
Xu, G. T. [1 ]
Wen, S. F. [2 ]
Guo, Y. Y. [1 ]
Huang, Q. [1 ]
机构
[1] Jieyang Peoples Hosp, Dept Orthoped, Jieyang, Peoples R China
[2] Guangzhou First Peoples Hosp, Dept Orthoped, Guangzhou, Guangdong, Peoples R China
来源
GENETICS AND MOLECULAR RESEARCH | 2016年 / 15卷 / 02期
关键词
Tissue inhibitor of metalloproteinase-2; Matrix metalloproteinase-2; Cervical disc herniation; INTERVERTEBRAL DISC; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; MMP-2; TIMP-2; AGGRECANASES; MODEL;
D O I
10.4238/gmr.15027594
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aim of the current study was to examine matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) expression in patients with cervical disc herniation (CDH). A total of 127 specimens from CDH patients undergoing posterior spinal surgery were obtained for the case group, which was divided into three subgroups: lateral protrusion (N = 102), median protrusion (N = 18), and paramedian protrusion (N = 7). Another 55 specimens from subjects who had cervical spine trauma and underwent spinal canal decompression were obtained for the control group. Routine hematoxylin and eosin staining was performed for pathological diagnosis. Immunohistochemical (IHC) analysis was used to determine MMP-2 and TIMP-2 expression. Under light microscopy, MMP-2-positive cells presented brown-yellow or dark brown staining in the cell membrane or cytoplasm. MMP-2 expression in the case group was significantly higher than that in controls (P < 0.05). Furthermore, MMP-2 expression in the lateral and median protrusion groups was significantly higher compared to that in the paramedian protrusion group (both P < 0.05), while there was no apparent difference in MMP-2 expression between the lateral and median protrusion groups (P > 0.05). IHC results showed that TIMP-2 expression in cases was significantly lower than that in controls (P < 0.05). Spearman correlation analysis indicated that MMP-2 was negatively correlated with TIMP-2 expression (r = -0.418, P < 0.001). In conclusion, MMP-2 expression increased, whereas TIMP-2 expression decreased in CDH patients, suggesting that MMP-2 and TIMP-2 expression may contribute to CDH development.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Matrix metalloproteinase-2 regulates the expression of tissue inhibitor of matrix metalloproteinase-2
    Kimura, Kaoru
    Cheng, Xian Wu
    Nakamura, Kae
    Inoue, Aiko
    Hu, Lina
    Song, Haizhen
    Okumura, Kenji
    Iguchi, Akihisa
    Murohara, Toyoaki
    Kuzuya, Masafumi
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (11) : 1096 - 1101
  • [2] Serum metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in lung carcinoma patients
    Drzewiecka-Jedrzejczyk, Magdalena
    Wlazel, Rafal
    Terlecka, Monika
    Jablonski, Slawomir
    JOURNAL OF THORACIC DISEASE, 2017, 9 (12) : 5306 - 5313
  • [3] Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer
    Kanayama, H
    Yokota, K
    Kurokawa, Y
    Murakami, Y
    Nishitani, M
    Kagawa, S
    CANCER, 1998, 82 (07) : 1359 - 1366
  • [4] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines
    Afzal, S
    Lalani, EN
    Foulkes, WD
    Boyce, B
    Tickle, S
    Cardillo, MR
    Baker, T
    Pignatelli, M
    Stamp, GWH
    LABORATORY INVESTIGATION, 1996, 74 (02) : 406 - 421
  • [5] Expression of matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in oral squamous cell carcinomas
    Radhakrishnan, R.
    Shrestha, B.
    Bajracharya, D.
    ORAL ONCOLOGY, 2011, 47 : S84 - S84
  • [6] Polymorphisms in the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and the risk of human adenomyosis
    Kang, Shan
    Zhao, Xiwa
    Xing, Huimin
    Wang, Na
    Zhou, Rongmiao
    Chen, Shucheng
    Li, Wansheng
    Zhao, Jian
    Duan, Yanan
    Sun, Donglan
    Li, Yan
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2008, 49 (03) : 226 - 231
  • [7] Prognostic value of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in bladder carcinoma
    Xu, KX
    Hou, SK
    Du, ZJ
    CHINESE MEDICAL JOURNAL, 2002, 115 (05) : 743 - 745
  • [8] Effects of valsartan on matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in atrial fibrillation patients
    裴晓阳
    潘莹
    颜雯
    胡雪松
    SouthChinaJournalofCardiology, 2010, 11 (01) : 15 - 19
  • [9] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in colorectal carcinoma invasion and metastasis
    Li, Bing-Hui
    Zhao, Peng
    Liu, Shi-Zheng
    Yu, Yue-Ming
    Han, Mei
    Wen, Jin-Kun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (20) : 3046 - 3050
  • [10] Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium
    Chung, HW
    Lee, JY
    Moon, HS
    Hur, SE
    Park, MH
    Wen, Y
    Polan, ML
    FERTILITY AND STERILITY, 2002, 78 (04) : 787 - 795